169 related articles for article (PubMed ID: 24884853)
1. Acid suppressive agents and risk of Mycobacterium tuberculosis: case-control study.
Hsu WH; Kuo CH; Wang SS; Lu CY; Liu CJ; Chuah SK; Kuo FC; Chen YH; Huang YB; Hou MF; Wu DC; Hu HM
BMC Gastroenterol; 2014 May; 14():91. PubMed ID: 24884853
[TBL] [Abstract][Full Text] [Related]
2. Use of gastric acid-suppressive agents increases the risk of dementia in patients with upper gastrointestinal disease: A population-based retrospective cohort study.
Lin HC; Huang KT; Lin HL; Uang YS; Ho Y; Keller JJ; Wang LH
PLoS One; 2021; 16(3):e0249050. PubMed ID: 33765029
[TBL] [Abstract][Full Text] [Related]
3. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
4. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
[TBL] [Abstract][Full Text] [Related]
5. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
[TBL] [Abstract][Full Text] [Related]
6. Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.
Tamim H; Duranceau A; Chen LQ; Lelorier J
Drug Saf; 2008; 31(8):675-84. PubMed ID: 18636786
[TBL] [Abstract][Full Text] [Related]
7. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
8. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis.
Huang KW; Kuan YC; Luo JC; Lin CL; Liang JA; Kao CH
Eur J Intern Med; 2016 Jul; 32():91-5. PubMed ID: 27139916
[TBL] [Abstract][Full Text] [Related]
9. Association between acid-suppressive drug use and atopic dermatitis in patients with upper gastrointestinal diseases: A population-based retrospective cohort study.
Lin HC; Chen YY; Lin HL; Uang YS; Ho Y; Wang LH
J Clin Pharm Ther; 2021 Jun; 46(3):786-793. PubMed ID: 33403692
[TBL] [Abstract][Full Text] [Related]
10. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
[TBL] [Abstract][Full Text] [Related]
11. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
El-Serag HB; Fitzgerald S; Richardson P
Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
[TBL] [Abstract][Full Text] [Related]
13. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
14. The combined use of anti-peptic agents is associated with an increased risk of osteoporotic fracture: a nationwide case-control study.
Oh DJ; Nam JH; Lee HS; Moon YR; Lim YJ
Korean J Intern Med; 2024 Mar; 39(2):228-237. PubMed ID: 38321358
[TBL] [Abstract][Full Text] [Related]
15. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
17. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
[TBL] [Abstract][Full Text] [Related]
18. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
Pohle T; Domschke W
Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
[TBL] [Abstract][Full Text] [Related]
19. Esophagitis in Pediatric Esophageal Atresia: Acid May Not Always Be the Issue.
Yasuda JL; Clark SJ; Staffa SJ; Blansky B; Ngo PD; Hamilton TE; Smithers CJ; Jennings R; Manfredi MA
J Pediatr Gastroenterol Nutr; 2019 Aug; 69(2):163-170. PubMed ID: 30921254
[TBL] [Abstract][Full Text] [Related]
20. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
Dial S; Delaney JA; Barkun AN; Suissa S
JAMA; 2005 Dec; 294(23):2989-95. PubMed ID: 16414946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]